Isomorphic Labs

Isomorphic Labs, spun out of Google DeepMind, builds AI models for drug design built on the AlphaFold lineage. Pharmaceutical partners including Eli Lilly and Novartis use its design engine for small-molecule and biologic discovery. It has signed multi-billion-dollar pharma partnerships but had not brought a drug to clinical trials as of mid-2026.

Ecosystem functionThe best-capitalized AI drug-design lab, converting DeepMind's structural biology breakthroughs directly into pharmaceutical R&D.

Business modelPharma partnerships and milestones